Cargando…

Membranous nephropathy with acquired factor V inhibitor: a case report

BACKGROUND: Membranous nephropathy is one of the most common causes of nephrotic syndrome in adults. In contrast, acquired factor V inhibitor is a rare bleeding disorder. CASE PRESENTATION: A 62-year-old Asian man with a history of cerebral hemorrhage, purpura, eosinophilia and hyper immunoglobulin...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kitamura, Shinji, Misawa, Mahito, Namba, Sayaka, Tsuji, Kenji, Torigoe, Rikako, Shima, Midori, Makino, Hirofumi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2013
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3892019/ https://www.ncbi.nlm.nih.gov/pubmed/24360027 http://dx.doi.org/10.1186/1756-0500-6-553

Ejemplares similares

The level of urinary semaphorin3A is associated with disease activity in patients with minimal change nephrotic syndrome
por: Inoue-Torii, Akiko, et al.
Publicado: (2017)

Deep Learning Could Diagnose Diabetic Nephropathy with Renal Pathological Immunofluorescent Images
por: Kitamura, Shinji, et al.
Publicado: (2020)

Combination therapy with an angiotensin‐converting‐enzyme inhibitor and an angiotensin II receptor antagonist ameliorates microinflammation and oxidative stress in patients with diabetic nephropathy
por: Nakamura, Akihiko, et al.
Publicado: (2012)

Microinflammation in the pathogenesis of diabetic nephropathy
por: Shikata, Kenichi, et al.
Publicado: (2013)

Acquired Factor V Inhibitors in a Patient with End-stage Renal Disease
por: Kitazawa, Atsushi, et al.
Publicado: (2016)

Calcineurin Inhibitors in Membranous Nephropathy
por: Ponticelli, Claudio, et al.
Publicado: (2021)

Trophic Factors from Tissue Stem Cells for Renal Regeneration
por: Tsuji, Kenji, et al.
Publicado: (2015)

Sodium–Glucose Cotransporter 2 Inhibitors Work as a “Regulator” of Autophagic Activity in Overnutrition Diseases
por: Fukushima, Kazuhiko, et al.
Publicado: (2021)

Acatalasemic mice are mildly susceptible to adriamycin nephropathy and exhibit increased albuminuria and glomerulosclerosis
por: Takiue, Keiichi, et al.
Publicado: (2012)

A case of focal segmental glomerulosclerosis in an adult patient with hypogammaglobulinemia superimposed on membranoproliferative glomerulonephritis in childhood
por: Tsuji, Kenji, et al.
Publicado: (2012)

Acquired Factor V Inhibitor
por: Hirai, Daisuke, et al.
Publicado: (2016)

Paratubular basement membrane insudative lesions predict renal prognosis in patients with type 2 diabetes and biopsy-proven diabetic nephropathy
por: Mise, Koki, et al.
Publicado: (2017)

Sodium Glucose Co-Transporter 2 Inhibitor Ameliorates Autophagic Flux Impairment on Renal Proximal Tubular Cells in Obesity Mice
por: Fukushima, Kazuhiko, et al.
Publicado: (2020)

Semaphorin3A-Inhibitor Ameliorates Doxorubicin-Induced Podocyte Injury
por: Sang, Yizhen, et al.
Publicado: (2020)

Quantitative Trait Loci for Resistance to the Congenital Nephropathy in Tensin 2-Deficient Mice
por: Sasaki, Hayato, et al.
Publicado: (2014)

Anti-Factor V inhibitor in patients with autoimmune diseases: case report and literature review
por: Imashuku, Shinsaku, et al.
Publicado: (2011)

Membranous Nephropathy After Exposure to Immune Checkpoint Inhibitors
por: Benyahia, Rayane, et al.
Publicado: (2023)

Secretomes from Mesenchymal Stem Cells against Acute Kidney Injury: Possible Heterogeneity
por: Tsuji, Kenji, et al.
Publicado: (2018)

Immunomodulatory and Regenerative Effects of Mesenchymal Stem Cell-Derived Extracellular Vesicles in Renal Diseases
por: Tsuji, Kenji, et al.
Publicado: (2020)

MicroRNAs as Biomarkers for Nephrotic Syndrome
por: Tsuji, Kenji, et al.
Publicado: (2020)

Potential Strategies for Kidney Regeneration With Stem Cells: An Overview
por: Tsuji, Kenji, et al.
Publicado: (2022)

Epigenetic regulation of core genes linking to diabetic nephropathy progression: Lesson from FinnDiane type 1 diabetes study
por: Makino, Hirofumi, et al.
Publicado: (2023)

Membranous Nephropathy
por: Mathieson, Peter
Publicado: (1997)

Membranous nephropathy
por: Dantas, Márcio, et al.
Publicado: (2023)

Atypical Focal Choroidal Excavation with Macular Hole in a Patient with Alagille Syndrome
por: Misawa, Manami, et al.
Publicado: (2022)

Acquired Factor V Inhibitor Complicated with Immune Thrombocytopenia
por: Mima, Fuka, et al.
Publicado: (2021)

Characterization of anti-factor VIII antibody in a patient with acquired hemophilia A
por: Oh, Jisu, et al.
Publicado: (2013)

Membranous Nephropathy with Crescent after Hematopoietic Cell Transplantation
por: Kitamura, Mineaki, et al.
Publicado: (2018)

Anti-glomerular Basement Membrane Disease with Antiphospholipid Syndrome
por: Torigoe, Miki, et al.
Publicado: (2021)

Acquired von Willebrand Syndrome Complicating Nephrotic Syndrome: A Case of a Patient With Membranous Nephropathy
por: Sugase, Taro, et al.
Publicado: (2018)

Advances in the Management of Primary Membranous Nephropathy and Rituximab-Refractory Membranous Nephropathy
por: Teisseyre, Maxime, et al.
Publicado: (2022)

Membranous nephropathy and carbamazepine
por: Sangeetha, B., et al.
Publicado: (2014)

Immunology of membranous nephropathy
por: Akiyama, Shin'ichi, et al.
Publicado: (2019)

Membranous Nephropathy With Crescents
por: Alawieh, Rasha, et al.
Publicado: (2020)

Advances in Membranous Nephropathy
por: Ronco, Pierre, et al.
Publicado: (2021)

Rituximab in Membranous Nephropathy
por: Gauckler, Philipp, et al.
Publicado: (2021)

Perspectives in membranous nephropathy
por: Tomas, Nicola M., et al.
Publicado: (2021)

Lupus Membranous Nephropathy
por: Ponticelli, Claudio, et al.
Publicado: (2021)

Dasatinib-induced massive left chylothorax in a patient with chronic myeloid leukemia
por: Makimoto, Go, et al.
Publicado: (2022)

Immune checkpoint inhibitor associated reactivation of primary membranous nephropathy responsive to rituximab
por: Lin, Jamie S, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_g566pn37kb4d6mvifj3sf8htnj